Cargando…
Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts
Breast cancer is the most diagnosed cancer and is the leading cause of cancer mortality in women. Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer. Often, TNBC is not effectively treated due to the lack of specificity of conventional therapies and results in relapse and me...
Autores principales: | Mollah, Farhana, Varamini, Pegah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698629/ https://www.ncbi.nlm.nih.gov/pubmed/34944738 http://dx.doi.org/10.3390/biomedicines9121921 |
Ejemplares similares
-
Deep Learning-Based Artificial Intelligence to Investigate Targeted Nanoparticles’ Uptake in TNBC Cells
por: Ali, Rafia, et al.
Publicado: (2022) -
Breast Cancer Bone Metastasis: A Narrative Review of Emerging Targeted Drug Delivery Systems
por: Shao, Huimin, et al.
Publicado: (2022) -
Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51
por: Lee, Jung Ok, et al.
Publicado: (2019) -
The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020) -
Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
por: Ferrari, Paola, et al.
Publicado: (2022)